- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Undervalued Small Caps
Hong Kong Pharmaceuticals & Biotech Undervalued Small Caps
Results
4
Undervalued Small Caps
4 companies
Consun Pharmaceutical Group
Market Cap: HK$13.1b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.55
7D
-3.0%
1Y
95.4%
Essex Bio-Technology
Market Cap: HK$2.1b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$3.81
7D
-2.1%
1Y
33.2%
Medtide
Market Cap: HK$4.3b
A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.
3880
HK$29.20
7D
-3.5%
1Y
n/a
Tong Ren Tang Technologies
Market Cap: HK$5.6b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.44
7D
-0.4%
1Y
-12.4%